[HTML][HTML] Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
V Valentini, V Silvestri, A Bucalo, G Conti… - Frontiers in …, 2023 - frontiersin.org
Introduction Compared with breast cancer (BC) in women, BC in men is a rare disease with
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
V Valentini, V Silvestri, A Bucalo… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Compared with breast cancer (BC) in women, BC in men is a rare disease with
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
V Valentini, V Silvestri, A Bucalo, G Conti… - FRONTIERS IN …, 2023 - iris.uniroma1.it
Introduction: Compared with breast cancer (BC) in women, BC in men is a rare disease with
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology.
V Valentini, V Silvestri, A Bucalo, G Conti… - Frontiers in …, 2022 - europepmc.org
Methods In this study, NGS multigene gene panel sequencing, targeting 1.94 Mb of the
genome at 523 cancer-relevant genes (TruSight Oncology 500, Illumina), was used to …
genome at 523 cancer-relevant genes (TruSight Oncology 500, Illumina), was used to …
[HTML][HTML] Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
V Valentini, V Silvestri, A Bucalo, G Conti… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Methods In this study, NGS multigene gene panel sequencing, targeting 1.94 Mb of the
genome at 523 cancer-relevant genes (TruSight Oncology 500, Illumina), was used to …
genome at 523 cancer-relevant genes (TruSight Oncology 500, Illumina), was used to …
[PDF][PDF] Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
V Valentini, V Silvestri, A Bucalo, G Conti, M Karimi… - 2023 - iris.uniroma1.it
Methods: In this study, NGS multigene gene panel sequencing, targeting 1.94 Mb of the
genome at 523 cancer-relevant genes (TruSight Oncology 500, Illumina), was used to …
genome at 523 cancer-relevant genes (TruSight Oncology 500, Illumina), was used to …